Month: December 2020

Stock Investing

Let’s take a look at why Aethlon Medical, Inc. (Nasdaq: AEMD) dropped its value

Aethlon Medical, Inc. (Nasdaq: AEMD), closed down -11.16% to $2.07 at the last close, after a clinical medical product and technology organization concentrating on unmet needs of infectious diseases, oncology and inflammation, confirmed that the first patient had been treated in the Company’s first-in-human Early

Trading Signals

Oil And Gold End The Thursday Session In Green

On Thursday, December 17, oil prices updated their nine-month highs. In general, the sentiment on the commodity markets remained very positive, owing to the expectations of a positive impact of the population’s coronavirus vaccination, as well as the introduction of a new package of economic

Equity News

Oil Prices Rose Even In Presence Of Adverse Factors

On Tuesday 15 December, in the face of strengthening restrictive measures in a number of Western countries, oil gained about 1.1 percent in price. Moreover the news of continued growth in the production of oil in Libya puts pressure on the prices. The weakening of

Market Activity

U.S. Indices: Dow Jones, S&P 500 Took Negative Trend, Nasdaq Succeed To Add

After celebrating the launch of the U.S. coronavirus vaccine program, Wall Street ended Monday’s half-tone session in the face of the epidemic’s revival. The 300,000-dead Covid-19 mark was symbolically crossed in the U.S. on Monday, and New York City is contemplating re-shutting itself. Investors are

TOST Stock
Market Activity

U.S. Job Openings Rose In October, Canada Also Approved Covid Vaccine

On Wednesday, job openings on the macro-economic front in the U.S. stood at 6.652 million in October, compared to 6.3 million by consensus. The reading of the previous month has been updated to 6.494 million; the U.S. JOLTS’s Department of Labor study reveals. Wholesale inventories

Market Activity

U.S. Indices Closed In Green With New Records

The U.S. indices ended the trading session in positive territory on Tuesday, December 8, after the Food and Drug Administration (FDA) released first scientific evaluation, setting the stage for the government to give a go ahead to the Covid-19 vaccine developed by Pfizer and BioNTech

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.